lucanthone hydrochloride has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araújo, N; Couto, FF; Katz, N | 1 |
Fang, R; Grevelding, CG; Haeberlein, S; Hu, M; Li, X; Liu, L; Mughal, MN; Zhao, J; Zhao, L; Zhou, Y; Zhu, T | 1 |
2 other study(ies) available for lucanthone hydrochloride and imatinib mesylate
Article | Year |
---|---|
Imatinib activity on Schistosoma mansoni.
Topics: Animals; Benzamides; Dose-Response Relationship, Drug; Imatinib Mesylate; Mice; Parasite Load; Piperazines; Pyrimidines; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Time Factors | 2013 |
The ABL kinase inhibitor imatinib causes phenotypic changes and lethality in adult Schistosoma japonicum.
Topics: Amino Acid Sequence; Animals; Drug Resistance; Female; Gastropoda; Humans; Imatinib Mesylate; Male; Mice; Parasitic Sensitivity Tests; Protein Kinase Inhibitors; Schistosoma japonicum; Schistosoma mansoni; Schistosomiasis japonica; Schistosomicides; Sequence Alignment | 2019 |